CALCR
Basic information
Region (hg38): 7:93424486-93574730
Links
Phenotypes
GenCC
Source:
- osteoporosis (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CALCR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 25 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 50 | 50 | ||||
Total | 0 | 0 | 26 | 6 | 54 |
Variants in CALCR
This is a list of pathogenic ClinVar variants found in the CALCR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-93426338-G-A | Benign (Nov 10, 2018) | |||
7-93426384-T-G | not specified | Uncertain significance (May 30, 2024) | ||
7-93426391-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
7-93426412-C-T | CALCR-related disorder | Likely benign (Jun 06, 2019) | ||
7-93426422-GT-G | not specified | Uncertain significance (Jun 22, 2021) | ||
7-93426432-T-C | not specified | Uncertain significance (Oct 06, 2022) | ||
7-93426441-A-G | Bone mineral density quantitative trait locus 15 • CALCR-related disorder | Benign (Nov 10, 2018) | ||
7-93426442-G-T | not specified | Uncertain significance (Jun 23, 2023) | ||
7-93426496-C-A | Likely benign (May 21, 2018) | |||
7-93426516-G-C | not specified | Uncertain significance (Mar 21, 2023) | ||
7-93426534-C-T | not specified | Uncertain significance (Oct 18, 2021) | ||
7-93426555-A-G | not specified | Uncertain significance (Jan 10, 2022) | ||
7-93426915-A-G | Benign (Nov 10, 2018) | |||
7-93434086-G-T | Benign (Nov 10, 2018) | |||
7-93434389-G-GA | Benign (Jun 18, 2021) | |||
7-93434389-G-GAA | Benign (Jun 18, 2021) | |||
7-93434389-G-GAAAA | Benign (Jun 19, 2021) | |||
7-93434510-G-A | Benign (Nov 10, 2018) | |||
7-93434532-A-T | Benign (Nov 10, 2018) | |||
7-93434594-GA-G | Benign (Jun 20, 2021) | |||
7-93434594-G-GAA | Benign (Jun 18, 2021) | |||
7-93435803-G-C | Benign (Jun 18, 2021) | |||
7-93435814-T-A | Benign (Jun 18, 2021) | |||
7-93435824-TAATA-T | Benign (Jun 18, 2021) | |||
7-93435827-T-A | Benign (Jun 18, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CALCR | protein_coding | protein_coding | ENST00000359558 | 14 | 150244 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.12e-9 | 0.918 | 125683 | 0 | 61 | 125744 | 0.000243 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.515 | 263 | 288 | 0.915 | 0.0000158 | 3343 |
Missense in Polyphen | 105 | 117.34 | 0.8948 | 1434 | ||
Synonymous | 0.239 | 102 | 105 | 0.970 | 0.00000618 | 915 |
Loss of Function | 1.86 | 18 | 28.8 | 0.625 | 0.00000155 | 323 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000519 | 0.000516 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000302 | 0.000299 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000360 | 0.000359 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: This is a receptor for calcitonin. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. The calcitonin receptor is thought to couple to the heterotrimeric guanosine triphosphate-binding protein that is sensitive to cholera toxin.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);Osteoclast differentiation - Homo sapiens (human);RANKL-RANK (Receptor activator of NFKB (ligand)) Signaling Pathway;GPCRs, Class B Secretin-like;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Calcitonin-like ligand receptors;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.475
Intolerance Scores
- loftool
- 0.939
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.57
Haploinsufficiency Scores
- pHI
- 0.181
- hipred
- N
- hipred_score
- 0.452
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.718
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Calcr
- Phenotype
- homeostasis/metabolism phenotype; limbs/digits/tail phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; skeleton phenotype; immune system phenotype;
Gene ontology
- Biological process
- cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;positive regulation of cytosolic calcium ion concentration;positive regulation of gene expression;positive regulation of protein kinase A signaling;positive regulation of cell death;positive regulation of peptidyl-serine phosphorylation;cross-receptor inhibition within G protein-coupled receptor heterodimer;response to glucocorticoid;positive regulation of protein kinase B signaling;positive regulation of ERK1 and ERK2 cascade;amylin receptor signaling pathway;response to amyloid-beta;positive regulation of calcium ion import across plasma membrane
- Cellular component
- plasma membrane;integral component of plasma membrane;axon;amylin receptor complex 1;amylin receptor complex 2;amylin receptor complex 3
- Molecular function
- amyloid-beta binding;calcitonin gene-related peptide receptor activity;calcitonin receptor activity;protein binding;calcitonin binding;amylin receptor activity